185 related articles for article (PubMed ID: 10664529)
21. A conformation-dependent epitope in Addison's disease and other endocrinological autoimmune diseases maps to a carboxyl-terminal functional domain of human steroid 21-hydroxylase.
Nikoshkov A; Falorni A; Lajic S; Laureti S; Wedell A; Lernmark K; Luthman H
J Immunol; 1999 Feb; 162(4):2422-6. PubMed ID: 9973524
[TBL] [Abstract][Full Text] [Related]
22. Steroid 21-hydroxylase autoantibodies: measurements with a new immunoprecipitation assay.
Tanaka H; Perez MS; Powell M; Sanders JF; Sawicka J; Chen S; Prentice L; Asawa T; Betterle C; Volpato M; Smith BR; Furmaniak J
J Clin Endocrinol Metab; 1997 May; 82(5):1440-6. PubMed ID: 9141530
[TBL] [Abstract][Full Text] [Related]
23. Autoimmune adrenocortical failure in Norway autoantibodies and human leukocyte antigen class II associations related to clinical features.
Myhre AG; Undlien DE; Løvås K; Uhlving S; Nedrebø BG; Fougner KJ; Trovik T; Sørheim JI; Husebye ES
J Clin Endocrinol Metab; 2002 Feb; 87(2):618-23. PubMed ID: 11836294
[TBL] [Abstract][Full Text] [Related]
24. Low dose (1 microg) ACTH test in the evaluation of adrenal dysfunction in pre-clinical Addison's disease.
Laureti S; Arvat E; Candeloro P; Di Vito L; Ghigo E; Santeusanio F; Falorni A
Clin Endocrinol (Oxf); 2000 Jul; 53(1):107-15. PubMed ID: 10931087
[TBL] [Abstract][Full Text] [Related]
25. Autoantibodies in autoimmune polyendocrine syndrome type II.
Falorni A; Laureti S; Santeusanio F
Endocrinol Metab Clin North Am; 2002 Jun; 31(2):369-89, vii. PubMed ID: 12092456
[TBL] [Abstract][Full Text] [Related]
26. Autoantibodies against glutamic acid decarboxylase and 21-hydroxylase in Brazilian patients with type 1 diabetes or autoimmune thyroid diseases.
Silva RC; Sallorenzo C; Kater CE; Dib SA; Falorni A
Diabetes Nutr Metab; 2003 Jun; 16(3):160-8. PubMed ID: 14635733
[TBL] [Abstract][Full Text] [Related]
27. Two different cytochrome P450 enzymes are the adrenal antigens in autoimmune polyendocrine syndrome type I and Addison's disease.
Winqvist O; Gustafsson J; Rorsman F; Karlsson FA; Kämpe O
J Clin Invest; 1993 Nov; 92(5):2377-85. PubMed ID: 8227354
[TBL] [Abstract][Full Text] [Related]
28. Time course of 21-hydroxylase antibodies and long-term remission of subclinical autoimmune adrenalitis after corticosteroid therapy: case report.
De Bellis A A; Falorni A; Laureti S; Perrino S; Coronella C; Forini F; Bizzarro E; Bizzarro A; Abbate G; Bellastella A
J Clin Endocrinol Metab; 2001 Feb; 86(2):675-8. PubMed ID: 11158030
[TBL] [Abstract][Full Text] [Related]
29. Determination of 21-hydroxylase autoantibodies: inter-laboratory concordance in the Euradrenal International Serum Exchange Program.
Falorni A; Bini V; Betterle C; Brozzetti A; Castaño L; Fichna M; Kämpe O; Mellgren G; Peterson P; Chen S; Rönnelid J; Seissler J; Tiberti C; Uibo R; Yu L; Lernmark Å; Husebye E
Clin Chem Lab Med; 2015 Oct; 53(11):1761-70. PubMed ID: 25811668
[TBL] [Abstract][Full Text] [Related]
30. Autoantibodies against aromatic L-amino acid decarboxylase identifies a subgroup of patients with Addison's disease.
Söderbergh A; Rorsman F; Halonen M; Ekwall O; Björses P; Kämpe O; Husebye ES
J Clin Endocrinol Metab; 2000 Jan; 85(1):460-3. PubMed ID: 10634424
[TBL] [Abstract][Full Text] [Related]
31. Measuring adrenal autoantibody response: interlaboratory concordance in the first international serum exchange for the determination of 21-hydroxylase autoantibodies.
Falorni A; Chen S; Zanchetta R; Yu L; Tiberti C; Bacosi ML; Furmaniak J; Bini V; Dotta F; Eisenbarth GS; Smith BR; Betterle C
Clin Immunol; 2011 Sep; 140(3):291-9. PubMed ID: 21570358
[TBL] [Abstract][Full Text] [Related]
32. High diagnostic accuracy for idiopathic Addison's disease with a sensitive radiobinding assay for autoantibodies against recombinant human 21-hydroxylase.
Falorni A; Nikoshkov A; Laureti S; Grenbäck E; Hulting AL; Casucci G; Santeusanio F; Brunetti P; Luthman H; Lernmark A
J Clin Endocrinol Metab; 1995 Sep; 80(9):2752-5. PubMed ID: 7673419
[TBL] [Abstract][Full Text] [Related]
33. 21-hydroxylase autoantibody-negative Addison's disease in a 5-year-old boy with adrenal crisis and type 1 diabetes mellitus.
Chang JT; Chen YY; Chiu PC
J Pediatr Endocrinol Metab; 2010 Nov; 23(11):1201-5. PubMed ID: 21284337
[TBL] [Abstract][Full Text] [Related]
34. Premature ovarian failure: autoimmunity and natural history.
Betterle C; Rossi A; Dalla Pria S; Artifoni A; Pedini B; Gavasso S; Caretto A
Clin Endocrinol (Oxf); 1993 Jul; 39(1):35-43. PubMed ID: 8348706
[TBL] [Abstract][Full Text] [Related]
35. Autoantibody epitope mapping of the 21-hydroxylase antigen in autoimmune Addison's disease.
Song YH; Connor EL; Muir A; She JX; Zorovich B; Derovanesian D; Maclaren N
J Clin Endocrinol Metab; 1994 May; 78(5):1108-12. PubMed ID: 7513715
[TBL] [Abstract][Full Text] [Related]
36. Autoimmune Addison's disease--evidence for a role of steroid 21-hydroxylase autoantibodies in adrenal insufficiency.
Furmaniak J; Kominami S; Asawa T; Wedlock N; Colls J; Smith BR
J Clin Endocrinol Metab; 1994 Nov; 79(5):1517-21. PubMed ID: 7962352
[TBL] [Abstract][Full Text] [Related]
37. Analysis of autoantibody epitopes on steroid 21-hydroxylase using a panel of monoclonal antibodies.
Chen S; Sawicka J; Prentice L; Sanders JF; Tanaka H; Petersen V; Betterle C; Volpato M; Roberts S; Powell M; Smith BR; Furmaniak J
J Clin Endocrinol Metab; 1998 Aug; 83(8):2977-86. PubMed ID: 9709979
[TBL] [Abstract][Full Text] [Related]
38. Immunoprecipitation of steroidogenic enzyme autoantigens with autoimmune polyglandular syndrome type I (APS I) sera; further evidence for independent humoral immunity to P450c17 and P450c21.
Peterson P; Uibo R; Peränen J; Krohn K
Clin Exp Immunol; 1997 Feb; 107(2):335-40. PubMed ID: 9030872
[TBL] [Abstract][Full Text] [Related]
39. The natural history of 21-hydroxylase autoantibodies in autoimmune Addison's disease.
Wolff AB; Breivik L; Hufthammer KO; Grytaas MA; Bratland E; Husebye ES; Oftedal BE
Eur J Endocrinol; 2021 Apr; 184(4):607-615. PubMed ID: 34665570
[TBL] [Abstract][Full Text] [Related]
40. The purification and application of biologically active recombinant steroid cytochrome P450 21-hydroxylase: the major autoantigen in autoimmune Addison's disease.
Bratland E; Bredholt G; Mellgren G; Knappskog PM; Mozes E; Husebye ES
J Autoimmun; 2009 Aug; 33(1):58-67. PubMed ID: 19329278
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
